Instapath

company

About

Instapath provides digital imaging tools for rapid on-site pathology evaluation to repeat biopsy procedures and increase hospital revenue.

  • 1 - 10

Details

Last Funding Type
Grant
Last Funding Money Raised
$225K
Industries
Biotechnology,Health Care,Medical,Medical Device
Founded date
Jul 1, 2017
Number Of Employee
1 - 10
Operating Status
Active

Over 7 million Americans need biopsy procedures every year, costing over $8 billion; 20% of procedures fail to render an accurate diagnosis. Over 1 million patients have to go through costly, painful repeat biopsy procedures. Instapath makes digital microscopic imaging devices that improve rapid on-site evaluation (ROSE) of biopsies, reducing the need for repeat procedures and increasing operating room capacity and hospital revenue.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$1.22M
Instapath has raised a total of $1.22M in funding over 2 rounds. Their latest funding was raised on Mar 9, 2021 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 9, 2021 Grant $1M 1 National Science Foundation Detail
Jun 29, 2018 Grant $225K 1 National Science Foundation Detail

Investors

Number of Lead Investors
Number of Investors
2
1
Instapath is funded by 1 investors. National Science Foundation are the most recent investors.
Investor Name Lead Investor Funding Round
National Science Foundation Yes Grant